Abstract:Chrysi Keskinidou, Alice G Vassiliou, Ioanna Dimopoulou, Anastasia Kotanidou, Stylianos E Orfanos First Department of Critical Care Medicine and Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, "Evangelismos" Hospital, Athens, Greece Correspondence: Alice G Vassiliou; Stylianos E Orfanos, First Department of Critical Care Medicine and Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, "Evangelismos" Hospital, Athens, Greece, Tel +30 210 7235521, Fax +30 210 7239127, Email ; Acute respiratory distress syndrome (ARDS) is a life-threatening lung injury characterized by an acute inflammatory response in the lung parenchyma. Hence, it is considered as the most appropriate clinical syndrome to study pathogenic mechanisms of lung inflammation. ARDS is associated with increased morbidity and mortality in the intensive care unit (ICU), while no effective pharmacological treatment exists. It is very important therefore to fully characterize the underlying pathobiology and the related mechanisms, in order to develop novel therapeutic approaches. In vivo and in vitro models are important pre-clinical tools in biological and medical research in the mechanistic and pathological understanding of the majority of diseases. In this review, we will present data from selected experimental models of lung injury/acute lung inflammation, which have been based on clinical disorders that can lead to the development of ARDS and related inflammatory lung processes in humans, including ventilation-induced lung injury (VILI), sepsis, ischemia/reperfusion, smoke, acid aspiration, radiation, transfusion-related acute lung injury (TRALI), influenza, Streptococcus ( S .) pneumoniae and coronaviruses infection. Data from the corresponding clinical conditions will also be presented. The mechanisms related to lung inflammation that will be covered are oxidative stress, neutrophil extracellular traps, mitogen-activated protein kinase (MAPK) pathways, surfactant, and water and ion channels. Finally, we will present a brief overview of emerging techniques in the field of omics research that have been applied to ARDS research, encompassing genomics, transcriptomics, proteomics, and metabolomics, which may recognize factors to help stratify ICU patients at risk, predict their prognosis, and possibly, serve as more specific therapeutic targets. Keywords: acute respiratory distress syndrome, lung inflammation, mechanisms, biomarkers, omics In vivo and in vitro models have been important pre-clinical scientific tools in biological and medical research in the mechanistic and pathological understanding of the majority of diseases, as well as in their novel therapeutic approaches. Although in vitro methods are evolving, they cannot completely replace animal models. In vivo research using animal models can provide answers to the pathophysiology of the disease in a complex systemic manner, relevant to human responses. 1 The progression of the physiological changes and the host's responses in lung damage, especially in acute respiratory distress syndrome (ARDS), evolve over time, and therefore, they should be reproducible in the chosen animal model. The acute onset, disruption of the endothelial and epithelial barrier, and the prolonged hyper-inflammatory response in the lung, demonstrate the complexity of the experimental design and proper animal model establishment. Innate immune responses, including inflammatory cell infiltration and the "cytokine storm" are a hallmark of lung inflammation and ARDS. Cytokine storm is characterized by excessive inflammatory response to infectious and non-infectious diseases, in which pro-inflammatory cytokines are predominantly released. Cytokine storms in the systemic circulation and the lung alveolar environment can cause severe lung injury/ARDS. 2 Since extensive reviews describing in detail the above-mentioned mechanisms have been previously published, 3–6 we chose to focus on less commonly described lung injury mechanisms in experimental cell and animal models, and in related clinical acute lung inflammation, mainly ARDS. Although no existing animal model can reproduce every clinical aspect of ARDS and related inflammatory lung processes, they do provide important information about key elements of human response in lung pathologies. 7 The lung injury caused by the application of mechanical ventilation is called ventilator-induced lung injury (VILI). 7 In this review we will only discuss VILI induced by mechanical forces, where the observed damage is the product of mechanical stretch and cellular mechanotransduction. The overstretching of the alveolar epithelium induces inflammatory responses, activation of capillary endothelial cells, irreversible opening of -Abstract Truncated-

Secretory Autophagosomes from Alveolar Macrophages Exacerbate Acute Respiratory Distress Syndrome by Releasing IL-1β

Protective Role of Adipose-Derived Stem Cells in Staphylococcus aureus-Induced Lung Injury is Mediated by RegIIIγ Secretion.

Single-Cell RNA Sequencing and Transcriptome Analysis Revealed the Immune Microenvironment and Gene Markers of Acute Respiratory Distress Syndrome

Significance of Pyroptosis in Immunoregulation and Prognosis of Patients with Acute Respiratory Distress Syndrome: Evidence from RNA-Seq of Alveolar Macrophages

Role of Lipopolysaccharides in the Inflammation and Pyroptosis of Alveolar Epithelial Cells in Acute Lung Injury and Acute Respiratory Distress Syndrome

Α1-Adrenoceptor Stimulation Ameliorates Lipopolysaccharide-Induced Lung Injury by Inhibiting Alveolar Macrophage Inflammatory Responses Through NF-κB and ERK1/2 Pathway in ARDS

Impaired alveolar macrophage 11β-hydroxysteroid dehydrogenase type 1 reductase activity contributes to increased pulmonary inflammation and mortality in sepsis-related ARDS

The Role of Macrophages and Alveolar Epithelial Cells in the Development of ARDS

The role of lung macrophages in acute respiratory distress syndrome

Acute Respiratory Distress Syndrome is a TH17-like and Treg immune disease

Exosomes Derived From Alveolar Epithelial Cells Promote Alveolar Macrophage Activation Mediated by miR-92a-3p in Sepsis-Induced Acute Lung Injury

Abscisic acid for acute respiratory distress syndrome therapy by suppressing alveolar macrophage pyroptosis via upregulating acyloxyacyl hydrolase expression

ANKRD22 aggravates sepsis-induced ARDS and promotes pulmonary M1 macrophage polarization

Identification and Validation of Candidate Genes Dysregulated in Alveolar Macrophages of Acute Respiratory Distress Syndrome

Progress in preclinical studies of macrophage autophagy in the regulation of ALI/ARDS

PP2ACα of Alveolar Macrophages Is a Novel Protective Factor for LPS-Induced Acute Respiratory Distress Syndrome

Alpha2A-adrenoceptor deficiency attenuates lipopolysaccharide-induced lung injury by increasing norepinephrine levels and inhibiting alveolar macrophage activation in acute respiratory distress syndrome.

Mechanistic Understanding of Lung Inflammation: Recent Advances and Emerging Techniques

Insulin reverses impaired alveolar fluid clearance in ARDS by inhibiting LPS-induced autophagy and inflammatory

RvD1 improves resident alveolar macrophage self-renewal via the ALX/MAPK14/S100A8/A9 pathway in acute respiratory distress syndrome

The Complex Immune Cell Composition and Cellular Interaction in the Alveolar Compartment of Patients with Acute Respiratory Distress Syndrome